ADHS 2019

The ADHS is excited to announce that its next bi-annual conference will be held between 12 and 15 June 2019, at the David F. Musto Center for Drug Policy Studies, Shanghai University, China. The conference will be organised by Prof. Jim Mills, of the University of Strathclyde and Prof. Yong-an Zhang of Shanghai University, who […] […]

Read more "ADHS 2019"

Big Pharma Round-Up II

Here is a snapshot of the past week in Big Pharma news.  This is coming at you a little early because of the Christmas slowdown. Happy holidays. To kick off: The drug industry spent big! Threats to high drug prices prompted biggest lobbying/PR/advertising/influence-buying surge by trade group PhRMA in nearly a decade. We got their […]

Read more "Big Pharma Round-Up II"

Fracture

Playing soccer has been a hobby/passion/thing to do for the majority of my life. There’ve been no significant injuries to speak of. Until now. So let’s talk about ‘the knee’ and pain. A reckless and ridiculous challenge during my last game resulted in a minor fracture of the knee – and some major sit-on-my-butt time. […]

Read more "Fracture"

Are you an Anti-Vaxxer?

Why do we question vaccines? And who are the thought leaders involved? Are they respectable, or are they hacks? And, more importantly, what can we glean from past debates about vaccines? In Elena Conis’s new book, we get a sense of this – and so much more. In the newest edition of Social History of […]

Read more "Are you an Anti-Vaxxer?"

In the Weeds: Understanding Government Action and Canada’s Marijuana Industry

What is happening with Canadian marijuana policy? We seem to be stuck in the weeds. And there’s a fog of confusion. According to Jim Bronskill, there are the 9 major factors that have driven the Canadian government’s “federal marijuana moves” over the past few months. The key source for him was a November 2015 ministerial briefing […]

Read more "In the Weeds: Understanding Government Action and Canada’s Marijuana Industry"